These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15173206)

  • 1. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.
    Hoyer BF; Moser K; Hauser AE; Peddinghaus A; Voigt C; Eilat D; Radbruch A; Hiepe F; Manz RA
    J Exp Med; 2004 Jun; 199(11):1577-84. PubMed ID: 15173206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lived plasma cells and their contribution to autoimmunity.
    Hoyer BF; Manz RA; Radbruch A; Hiepe F
    Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
    Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
    J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.
    Klinman DM
    J Clin Invest; 1990 Oct; 86(4):1249-54. PubMed ID: 2212009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lived plasma cells in immunity and immunopathology.
    Moser K; Muehlinghaus G; Manz R; Mei H; Voigt C; Yoshida T; Dörner T; Hiepe F; Radbruch A
    Immunol Lett; 2006 Mar; 103(2):83-5. PubMed ID: 16280169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge.
    Luger EO; Fokuhl V; Wegmann M; Abram M; Tillack K; Achatz G; Manz RA; Worm M; Radbruch A; Renz H
    J Allergy Clin Immunol; 2009 Oct; 124(4):819-26.e4. PubMed ID: 19815119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
    Neubert K; Meister S; Moser K; Weisel F; Maseda D; Amann K; Wiethe C; Winkler TH; Kalden JR; Manz RA; Voll RE
    Nat Med; 2008 Jul; 14(7):748-55. PubMed ID: 18542049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic phenomenon of immune effector cells in autoimmune NZB x NZW F1 mice.
    Chen YY; Suen JL; Wu WM; Chiang BL
    J Microbiol Immunol Infect; 1999 Jun; 32(2):83-9. PubMed ID: 11561580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease.
    Jiang Y; Hirose S; Hamano Y; Kodera S; Tsurui H; Abe M; Terashima K; Ishikawa S; Shirai T
    J Immunol; 1997 Jan; 158(2):992-7. PubMed ID: 8993021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.
    Yachimovich-Cohen N; Fischel R; Bachar N; Yarkoni Y; Eilat D
    Eur J Immunol; 2003 Sep; 33(9):2469-78. PubMed ID: 12938223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to cope with pathogenic long-lived plasma cells in autoimmune diseases.
    Hoyer BF; Mumtaz IM; Yoshida T; Hiepe F; Radbruch A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii87-9. PubMed ID: 19022822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
    Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
    Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice.
    Cheng Q; Khodadadi L; Taddeo A; Klotsche J; F Hoyer B; Radbruch A; Hiepe F
    Eur J Immunol; 2018 Jun; 48(6):1020-1029. PubMed ID: 29427452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.